• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Patient Case 1: Managing Geriatric Syndrome Through Targeted Glycemic Goals

Opinion
Video

A panel of medical experts presents a case study featuring a 68-year-old woman exhibiting classic diabetes symptoms—polyuria, polydipsia, and significant weight loss—along with a notably elevated glucose level of 458 mg/dL.

Recent Videos
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management / Image credit: ©MichaelVi/AdobeStock

Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management

Sydney Jennings
November 26th 2024
Article

The investigational weight loss drug showed substantial weight loss among people with obesity or overweight with or without T2D without plateaus.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity / Image credit: ©missbobbit/AdobeStock

New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity

Sydney Jennings
November 6th 2024
Article

SYNCHRONIZE-1 and -2 will provide "robust evidence" on the safety, efficacy, and tolerability of survodutide in adults with obesity with or without T2D.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Oral Semaglutide Linked to Lower Risk of MACE: Daily Dose / image credit: ©New Africa/AdobeStock

Oral Semaglutide Linked to Lower Risk of MACE: Daily Dose

Sydney Jennings
November 1st 2024
Article

Your daily dose of the clinical news you may have missed.

GLP-1RAs Reduce the Risk of Early-Onset Colorectal Cancer in Adults with T2D / Image credit: American College of Gastroenterology (ACG)

GLP-1RAs Reduce the Risk of Early-Onset Colorectal Cancer in Adults with T2D

Sydney Jennings
October 31st 2024
Article

ACG 2024: New study results indicate GLP-1 RAs have a potentially protective role to play in combating EO-CRC, the incidence of which is notably rising worldwide.

© 2024 MJH Life Sciences

All rights reserved.